Table 1.

Clinico-pathological characteristics of the patients

	n	Percent
Grade
2	10	14
3	62	86
Stage (FIGO)
II	3	4
III	59	82
IV	10	14
Peritoneal carcinomatosis
No	8	11
Yes	64	89
Residual macroscopic tumor rest
No	52	72
Yes	20	28
Primary platinum sensitivity*
Sensitive	48	67
Resistant	24	33

*Platinum sensitivity is defined as relapse-free survival for at least six months after the end of initial platinum-based chemotherapy